American biopharmaceutical research companies are working on 100 new medicines and vaccines against HIV/AIDS and related conditions.
In its new report, the Pharmaceutical Research and Manufacturers of America (PhRMA) states that many novel approaches are being taken to overcome the disease.
For example, a medicine under development is designed to spare healthy cells by attacking only infected cells. A new class of anti-HIV medicines is intended to prevent the HIV virus from breaking through cell membranes. One vaccine being worked on is administered through a skin patch. Another vaccine in development uses a weakened common cold adenovirus that helps boost the immune system.